13F HOLDINGS REPORT
venBio Partners LLC
Quarter ended Q4 2025 · Filed February 17, 2026 · Accession 0000905148-26-000841
Total Value
$216.3M
Positions
6
Other Managers
0
Confidential Omitted
No
Holdings (6)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | PHARVARIS N V | PHVS | 4,639,304 | $128.7M | 59.53% |
| 2 | ALUMIS INC | ALMS | 4,619,803 | $45.1M | 20.85% |
| 3 | HARMONY BIOSCIENCES HLDGS IN | HRMY | 489,194 | $18.3M | 8.46% |
| 4 | ALX ONCOLOGY HLDGS INC | ALXO | 9,699,925 | $11.0M | 5.07% |
| 5 | LYELL IMMUNOPHARMA INC | LYEL | 337,697 | $10.4M | 4.81% |
| 6 | ARTIVA BIOTHERAPEUTICS INC | ARTV | 648,507 | $2.8M | 1.29% |